Michigan Hematology and Oncology Consultants

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer	DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, milker's nodule, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, vaccinia, viral infectious disease	Recruiting	Phase 2	2026-06-04		NCT06463665

Clinical trials